Breast Cancer Clinical Trial
Evaluating the Shared Decision Making Process Scale in Cancer Screening Decisions
Summary
The purpose of this retrospective observational study is to evaluate the performance of the Shared Decision Making Process scale in a sample of patients who have received a decision aid about the decision to screen or not screen for breast cancer, colon cancer, prostate cancer, or lung cancer.
Full Description
This is a retrospective observational study that will examine the performance of the Shared Decision Making Process in a sample of patients who made a decision about cancer screening in the last 2 years. Patients from 4 hospitals who have received a patient decision aid for breast, colon, prostate, or lung cancer screening will be screened for eligibility. A random sample of eligible patients will be sent a one-time survey. The survey asks patients about their experiences talking with healthcare providers about the specific cancer screening decision. The survey includes the Shared Decision Making Process scale, knowledge, preferences, decisional conflict and decision regret. The study will obtain 400 completed surveys, or 100 for each cancer topic.
The sample consists of patients who received a decision aid for cancer screening within the last two years and meet specific qualifications.
All analyses will be conducted separately for each group, and results may be pooled. First, study staff examine the descriptives for the Shared Decision Making Process items. Study staff will also test several hypotheses to examine performance of the scores such as whether higher shared decision making process scores are associated with less decisional conflict and less regret.
Eligibility Criteria
Inclusion Criteria:
Breast Cancer group
Female sex
Between ages of 35-55
No previous diagnosis of breast cancer
Colon Cancer Group
Between ages of 45-75
No previous diagnosis of colon cancer
Prostate Cancer Group
Male sex
Between ages of 45-74
No previous diagnosis of prostate cancer
Lung Cancer Group
Between ages of 50-80
No previous diagnosis of lung cancer
Exclusion Criteria:
Breast Cancer group
Unable to confirm primary language is English
History of breast cancer
Severe cognitive impairment who cannot consent for themselves
Colon Cancer Group
Unable to confirm primary language is English
History of colon cancer
Severe cognitive impairment who cannot consent for themselves
Prostate Cancer Group
Unable to confirm primary language is English
History of prostate cancer
Severe cognitive impairment who cannot consent for themselves
Lung Cancer Group
Unable to confirm primary language is English
History of lung cancer
Severe cognitive impairment who cannot consent for themselves
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Boston Massachusetts, 02114, United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.